Yeti Holdings (YETI) Offers December 19th Options
Put Contract Analysis: The $32.50 put contract for YETI has a bid of 65 cents, allowing investors to buy shares at a cost basis of $31.85, which is a 5% discount from the current price of $34.31. There is a 65% chance the contract may expire worthless, offering a potential 2.00% return on cash commitment.
Call Contract Strategy: The $37.50 call contract has a bid of 70 cents, and if shares are purchased at $34.31 and the call is sold, it could yield an 11.34% return if exercised. There is a 57% chance this contract may also expire worthless, providing a potential 2.04% additional return.
Volatility Insights: The implied volatility for the put contract is 57% and for the call contract is 62%, while the actual trailing twelve-month volatility is calculated at 46%.
YieldBoost Concept: Both the put and call contracts offer a "YieldBoost," with the put providing an annualized return of 11.40% and the call offering 11.63% if they expire worthless.
Trade with 70% Backtested Accuracy
Analyst Views on YETI
About YETI
About the author

- Share Increase Details: Reinhart Partners increased its Yeti holdings by 373,641 shares in Q4 2025, valued at approximately $14.37 million, bringing the total position to $134.08 million, which is a $45.76 million increase from the previous quarter, reflecting positive trading and price movement effects.
- Market Performance Analysis: As of February 10, 2026, Yeti's share price stood at $47.06, representing a 30.2% increase over the past year, outperforming the S&P 500 by 15.79 percentage points, indicating strong market performance and investor confidence.
- Financial Overview: Yeti has a market capitalization of $3.66 billion, with a trailing twelve-month revenue of $1.83 billion and a net income of $160.31 million, showcasing growth potential despite pressures from rising tariff costs.
- Future Outlook and Challenges: Yeti plans to increase its share repurchase target to $300 million and has updated its sales and free cash flow guidance, maintaining optimism about future performance despite challenges from tightening consumer spending and supply chain issues.
- AppLovin's Current Status: AppLovin has experienced a decline in performance since the beginning of the year.
- Potential for Recovery: Analysts from Needham & Company suggest that successes in the company's new e-commerce segment could positively impact its stock.
- Stock Performance: Yeti Holdings' stock has surged 44% since the Q3 2025 earnings report, currently trading around $48 per share, nearing levels not seen since December 2023, indicating strong market confidence in its growth prospects.
- Margin Decline: Despite a drop in gross margin from 58.2% to 55.9% and adjusted operating margins at 13.7%, the brand retains significant pricing power, reflecting its competitive edge in the premium consumer goods market.
- International Sales Growth: Yeti's international sales grew by 14% in Q3 2025, now representing 20% of total revenue, a substantial increase from 2% in 2018, highlighting its potential for global market expansion, particularly in Asia.
- Stock Buyback Plan: Yeti repurchased $150 million in stock in Q3 2025 and raised its full-year buyback target from $200 million to $300 million, demonstrating management's confidence in future cash flow and shareholder returns.
- Margin Decline: Yeti's gross margin fell from 58.2% to 55.9% in Q3, primarily due to tariffs and product mix changes, indicating pressure on profitability that could affect investor confidence moving forward.
- International Expansion Potential: Despite challenges, Yeti's international sales grew by 14% in Q3, now representing 20% of total revenue, highlighting the company's growth potential in global markets, particularly in Asia.
- Supply Chain Diversification: Management plans to accelerate its exit from Chinese manufacturing, projecting that by 2026, exposure to China will be less than 5% of costs, aiming to mitigate tariff impacts and enhance supply chain flexibility.
- Stock Buyback Program: Yeti repurchased $150 million of stock in Q3 2025 and raised its full-year buyback target from $200 million to $300 million, reflecting confidence in future cash flows and commitment to shareholders.
- Rating Upgrade: Deutsche Bank upgraded Coupang from hold to buy, citing the company's strong resilience against regulatory scrutiny, particularly after facing a record antitrust fine in June 2024, which has not diminished its market position.
- Biotech Outlook: Goldman Sachs upgraded BioNTech from neutral to buy, highlighting the company's strategic suite of oncology programs targeting a potential market exceeding $100 billion, with key data expected to unlock in 2026, positioning it for leadership in emerging product cycles.
- Market Challenges: Barclays downgraded HP from equal weight to underweight, noting that the company faces significant long-term challenges in both PCs and printing, which will likely keep the stock under pressure in 2026 despite its current inexpensive valuation and lack of catalysts.
- EV Market Positioning: Macquarie upgraded Nio from market perform to outperform, asserting that the company is well-positioned to navigate the current headwinds in the Chinese electric vehicle market, thereby maintaining its competitive edge.

- Topgolf Callaway Upgrade: Keybanc analyst Noah Zatzkin upgraded Topgolf Callaway Brands Corp. (NYSE:MODG) from Sector Weight to Overweight with a price target of $17, indicating a significant increase from its Thursday closing price of $14.68, reflecting optimism about future growth.
- Rocket Lab Price Target Increase: Morgan Stanley analyst Kristine Liwag upgraded Rocket Lab Corp. (NASDAQ:RKLB) from Equal-Weight to Overweight and raised the price target from $67 to $105, demonstrating confidence in its market performance, with shares closing at $90.76 on Thursday.
- Grab Holdings Rating Change: HSBC analyst Piyush Choudhary upgraded Grab Holdings Ltd. (NASDAQ:GRAB) from Hold to Buy with a price target of $6.2, a notable increase from its Thursday closing price of $4.39, indicating a positive outlook on its future business development.
- BioNTech Price Target Upgrade: Goldman Sachs analyst Asad Haider upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy and raised the price target from $115 to $142, reflecting confidence in its product prospects, with shares closing at $106.07 on Thursday.








